| Nuclear imaging and cervical cancer. | |
| | |
MedLine Citation:
|
PMID: 19204660 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The staging of patients with cervical cancer is in accordance with the International Federation of Gynecology and Obstetrics (FIGO) clinical staging system. The traditional and current radiographic imaging studies allowed by FIGO to influence the clinical stage of the disease are the chest X-ray, the intravenous urogram and plain X-rays of the skeleton. The development and use of complimentary imaging studies may guide and direct therapy, but it does not change the clinical stage of the disease. Other X-ray studies that have been used are the barium enema and the lymphangiogram. Both computerized tomography (CT) and magnetic resonance imaging (MRI) have become commonplace in the evaluation of these patients. Most recently, position emission tomography (PET) with CT (PET/CT) is the preferred whole-body imaging study for patients with invasive cervical cancer. Single photon emission computed tomography (SPECT) combined with CT, the SPECT/CT, is also now being utilized in patients with cervical cancer. These new imaging modalities permit increased accuracy in the diagnosis and staging of cervical cancer, improve the selection and guidance of therapy, reduce uncertainties in the monitoring of response to therapy, and provide a means for objective long-term surveillance. |
| | |
Authors:
|
P W Grigsby |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Minerva ginecologica Volume: 61 ISSN: 0026-4784 ISO Abbreviation: Minerva Ginecol Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-02-10 Completed Date: 2009-07-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400731 Medline TA: Minerva Ginecol Country: Italy |
Other Details:
|
Languages: eng Pagination: 45-51 Citation Subset: IM |
Affiliation:
|
Department of Radiation Oncology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University Medical Center, St. Louis, MO 63110, USA. pgrigsby@wustl.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Monitoring Female Fluorodeoxyglucose F18 / diagnostic use Humans Neoplasm Staging Positron-Emission Tomography* Practice Guidelines as Topic Predictive Value of Tests Radiopharmaceuticals / diagnostic use Sensitivity and Specificity Tomography, Emission-Computed, Single-Photon* Uterine Cervical Neoplasms / pathology, radionuclide imaging* |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of laparoscopy in ovarian carcinoma
Next Document: Robotic radical hysterectomy.